COVID-19 sent its dietary supplement sales soaring but a year on Bayer has been able to solidify those initial gains by its Nutritionals franchise.
While Nutritionals turnover only edged up by 0.6% - 4.7% adjusted for currency and portfolio effects – to €353m ($426m) in the first quarter, Bayer achieved this gain after posting a 32% jump in turnover in the prior-year period
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?